BCMA and CD19 Targeted Fast Dual CAR-T for BCMA+ Refractory/Relapsed Multiple Myeloma
Clinical trial NCT04236011 · UNKNOWN
Trial details
- NCT number
- NCT04236011
- Sponsor
- Shanghai Changzheng Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-16
- Primary completion
- 2022-07-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.